ArticleNutrition & metabolism2026
Maternal red blood cell folate metabolites were dynamically associated with neonatal amino acids and acylcarnitines in heel blood: a prospective cohort study.
Article in Nutrition & metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundAnimal studies indicate maternal folic acid intake alters offspring amino acids (AAs) and fatty acid profiles, affecting their long-term health. However, human data on specific folate metabolites remain limited. We explored their dynamic associations with neonatal AAs and acylcarnitines (ACs).
methodsWe conducted a prospective cohort study, involving 4130 singleton pregnant women and their neonates. Maternal total folate and related metabolites in red blood cell (RBC), including 5-methyltetrahydrofolate (5-MTHF), tetrahydrofolate (THF), 5-formyltetrahydrofolate (5-CHO-THF), and unmetabolized folic acid (UMFA), were measured in 6-17 (T1), 20-26 (T2), and 32-36 (T3) gestational weeks. Neonatal metabolites, including 11 AAs and 31 ACs, were routinely tested 72 h postpartum using heel blood samples. Linear regression and pathway analysis were used to evaluate associations between maternal folate metabolites with neonatal metabolic pathways.
results5-MTHF and total folate levels significantly increased from T1 to T2 (p < 0.001), and stabilized from T2 to T3 (p > 0.05). THF and 5-CHO-THF levels showed a continuous upward trend (p < 0.001). Conversely, UMFA declined throughout pregnancy (p < 0.001). Total folate and 5-MTHF showed no significant correlations with neonatal metabolism. THF were associated with multiple neonatal metabolites, and the associations peaked in T1 and declined in T2 and T3. THF in T1 positively correlated with phenylalanine and tyrosine, involved in the phenylalanine and tyrosine metabolism. And it was positively associated with 7 ACs and negatively with 9 ACs, involved in the fatty acids β-oxidation. THF in T2 or T3 positively related to arginine, and negatively with citrulline, glycine, and ornithine, involved in the urea cycle and arginine and proline metabolism. 5-CHO-THF displayed similar and weaker impacts, correlated with fatty acids β-oxidation only in T1. UMFA exhibited different and weaker influence, related to the urea cycle, arginine and proline metabolism only in T1.
conclusionsAlthough maternal total folate and 5-MTHF levels showed no significant association with neonatal metabolites, maternal certain folate metabolites, especially THF, exhibited trimester-specific associations with neonatal metabolic pathways, warranting clinical attention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.